Company: MCGAU
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076738
Chunk: 62

Company: Yorkville Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 62
---
 exchange, reorganization or other
similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities
or other property.

Promissory Note — Related Party

The Sponsor agreed to loan the Company an aggregate of up to $300,000
to be used for a portion of the expenses of the Initial Public Offering (the “Promissory Note”). The Promissory Note was non-interest
bearing, unsecured and due at the earlier of March 25, 2026, or the closing of the Initial Public Offering. As of June 30, 2025, the Company
had borrowed $124,723 under the Promissory Note. The Promissory Note was non-interest bearing and $124,723 is outstanding as of June 30,
2025.

Related Party Loans

In addition, in order to finance transaction costs
in connection with its initial Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes
its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, such loans
may be convertible into private placement-equivalent units of the post-Business Combination entity at a price of $10.00 per unit (“Working
Capital Units”), with each unit comprised of one Class A ordinary share (“Working Capital Share”) and one-third
of one warrant to purchase one Class A ordinary share at an exercise price of $11.50 per share (“Working Capital Warrant”).
As of June 30, 2025, the Company had no borrowings under the Working Capital Loans.

Additionally, in order to finance potential extensions, the Sponsor
or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company up to $3,450,000
in extension loans (assuming the underwriters exercise their over-allotment option and no Public Shares have been redeemed at the time
of each extension), as may be required (“Extension Loans”). The Extension Loans may be convertible private placement-equivalent
units of the post